(Date:12/4/2009)...MUS, N.J., Dec. 4 Movado... & Co. Jewelers, Atlanta, Georgia, shared in a... Open quarterfinalist Melanie Oudin for her stella...e youngest American quarterfinalist at the Open si...cgi-bin/prnh/20091204/NY21184 ) ,, At a celebra...
(Date:12/4/2009)...FFERSON CITY, Mo., Dec. 4 Farmers ...rosetti, State Fire Marshal Randy Cole, and Brad B...afety program sponsored by Farmers called FireFa... at the Missouri Capitol December 9. ,, (Logo...ATH062 ) ,, "The call for fire safety comes fol...
(Date:12/4/2009)...INGTON, Dec. 4 The foll... the Heinz Family Philanthropies: ,, Credit Sen...th a significant contribution to the health care d...Americans living with Phenylketonuria (PKU) contro...ay others living with serious chronic conditions a...
(Date:12/4/2009)...lished this week in the Journal of Neurosurgery: ...g Juvenile Pilocytic Astrocytoma, or JPA, tumors i...Diffusion Tensor Imaging, or DTI. The sensitivity...rve fiber bundles in the brain. This information ...the tumor while avoiding damage to the fiber bundl...
(Date:12/4/2009)...ofile usually conveys true personality, study find... Does your profile on an online social network, su...good that it does, reports a new study, which find...stead of idealized identities. , "I was surpri...tion is that people are using their profiles to pr...
Breaking Medicine News(10 mins):Health News:Missouri Safety Day at the Capitol 2Health News:Health Leadership from Sen. Kerry and Sen. Casey: A Cure for Devastating Discrimination in Insurance Coverage for PKU Patients is on the Move 2Health News:Health Leadership from Sen. Kerry and Sen. Casey: A Cure for Devastating Discrimination in Insurance Coverage for PKU Patients is on the Move 3Health News:Online Identities Likely to Match Reality 2...y College London and Imperial College London have ...sy environment, such as a pub or in a crowd. // Th...ain work together to make sense of what it hears, ...perience of people who rely on cochlear implants, ...
...tting ready to go home.
Savage, who received ...mber last, says he feels sensation in his// new li...and in a ghastly machine press accident.
Savag...ansplant surgeries.
Savage, who reported sensa...
...r educated about the risks of exposing children to...h researchers.//
Results from a 14-year stu...e more likely to suffer respiratory problems.
...rn Australia say the evidence supports a ban on sm...
...ommended a maximum residue limit (MRL) of one part... the panel has suggested that the limit should be ...nsumer safety.
The panel is headed by the ch...f a controversy over pesticide residues in colas. ...
... issue in quality of life for patients with chroni...peaker, advocate and rheumatology patient, is// ou...nals address this aspect of care. During an hour-l... experiences. Perhaps most importantly, she’ll be ...
...rs seem to have tapped nature, in the form of an e...a possible cure for a notorious type of childhood/...a accounts for nearly 3% of all cancers in childre...'Brien of the University of California, San Franci...
Other Medicine News:Health News:Making Sense of the World Through a Cochlear Implant 2Health News:Destroying Taboos to Improve Patient Care 2...ONTO, Feb. 15 A seven-year, international,study p...es such as,acupuncture, neck manipulation and mass...ck pain than many current practices. Also included...exercises, education, neck,mobilization, low level...h as neck collars and ultrasound are not recommend...
...TH SAN FRANCISCO, Calif., Feb. 15 Cell,Genesys, I...an analysis,examining the potential association be...rostate cancer and increased patient survival in a...e refractory prostate cancer,(HRPC). More than 400...were,identified in the sera of the treated patient...
Other Medicine Technology:Seven-Year Neck Pain Study Sheds Light on Best Care 2Seven-Year Neck Pain Study Sheds Light on Best Care 3Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer 2Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer 3Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer 4Cell Genesys Reports Association Between Immune Response and Patient Survival in Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer 5